ABBV
AbbVie Inc
AbbVie Inc historical holders
total: 14
Torray Fund AbbVie Inc transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2025 Q2
- Held for:
- 4 quarters
- Latest activity:
- 2025 Q2
Torray Fund has been an institutional investor in AbbVie Inc (ABBV) since 2025 Q2. According to 2026 Q1 report, Torray Fund holds 69,640 shares with a market value of roughly $16.16M representing 4.73% of their equity portfolio. The fund/company first acquired ABBV in 2025 Q2, initially purchasing 69,640 shares.
Does Torray Fund still hold ABBV?
Yes, Torray Fund continues to hold AbbVie Inc (ABBV). According to their 2026 Q1 report, they maintain a position of 69,640 shares valued at approximately $16.16M, representing 4.73% of their equity portfolio.
When did Torray Fund first invest in ABBV?
Torray Fund first invested in AbbVie Inc (ABBV) in 2025 Q2 at the reported quarter-end price of $186.11 per share, acquiring 69,640 shares in their initial purchase.
What is Torray Fund's average cost basis for ABBV?
Based on historical transaction data, Torray Fund's estimated cost basis for AbbVie Inc (ABBV) is approximately $186.11 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $186.11
ABBV transactions history by Torray Fund
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
3.91%
|
69,640
|
$186.11
|
$12,960,700
|
new
|
+3.91%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.